Poojaben Dhorajiya, M.D.

Professional Background

My clinical focus is Gastrointestinal and Liver Pathology. Before becoming a member of the faculty at KU Pathology, I pursued Pathology residency at Mount Sinai Health System in New York, where I was also a chief resident. During my residency, I participated in the resident education committee as well as in the ASCP Pathology ambassador committee. I stayed in New York for another year and completed Surgical pathology fellowship at Memorial Sloan Kettering Cancer Center. Following that I pursued GI and Liver Pathology Fellowship from Beth Israel Deaconess Medical Center in Boston.

• Residency, Anatomic and Clinical Pathology, Icahn School of Medicine at Mount Sinai, New York, NY
• Clinical Fellowship, Oncologic Surgical Pathology, Memorial Sloan Kettering Cancer Center, New York, New York
• Clinical Fellowship, Gastrointestinal and Liver Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School , Boston, MA

Research

Overview

My academic research is focused on gastrointestinal, liver and pancreaticobiliary pathology. My research involves various medical liver diseases such as hepatic graft-versus-host disease, hepatic CVID, as well as gastrointestinal tract including inflammatory bowel diseases, colorectal cancers and pancreaticobiliary pathology.

• Solomon Daniel, Leigh Natasha, Bekhor Eliahu, Feferman Yael, Dhorajiya Poojaben, Feingold Daniela, Hofstedt Margaret, Aycart Samantha N, Golas Benjamin J, Sarpel Umut, Labow Daniel M, Magge Deepa R. 2021. The role of molecular biomarkers in outcomes and patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin. The Surgeon, 19 (6), e379-e385. https://doi.org/10.1016/j.surge.2020.11.002
• Yue LE, Samankan S, Liu X, Sharif KF, Everest S, Singh T, Dhorajiya P, Baik FM, Khorsandi A, Stevens TM, Brandwein-Weber M, Urken ML. 2020. Ten patients with high-grade transformation of acinic cell carcinomas: Expression profiling of β-catenin and cyclin D1 is useful.. Pathology, research and practice, 216 (2), 152767
• Berger Y., Sullivan B.J., Leigh N.L., Bekhor E.Y., Dhorajiya P., Mani M., Magge D.R., Cha D., Sarpel U., Hiotis S.P., Labow D.M., Ward S.C., Golas B.J., Cohen N.A.. 2022. Gallbladder Cancer: A Single-Institution 10-year experience-Analysis of adenocarcinoma subtypes and tumors arising from intracholecystic papillary neoplasms. Annals of Surgical Oncology , 23 (8), 5167-5175